Zhao, H., & Cai, J. (2021). Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World journal of gastroenterology : WJG, 27(47), 8069-8080. https://doi.org/10.3748/wjg.v27.i47.8069
Chicago Style (17th ed.) CitationZhao, Hai-Tao, and Jian-Qiang Cai. "Chinese Expert Consensus on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma." World Journal of Gastroenterology : WJG 27, no. 47 (2021): 8069-8080. https://doi.org/10.3748/wjg.v27.i47.8069.
MLA (9th ed.) CitationZhao, Hai-Tao, and Jian-Qiang Cai. "Chinese Expert Consensus on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma." World Journal of Gastroenterology : WJG, vol. 27, no. 47, 2021, pp. 8069-8080, https://doi.org/10.3748/wjg.v27.i47.8069.